05/15/2026 | Press release | Distributed by Public on 05/15/2026 11:44
| Page | ||||||||
|
Statements Regarding Forward-Looking Information
|
1
|
|||||||
|
PART I
|
FINANCIAL INFORMATION
|
3
|
||||||
|
Item 1.
|
Unaudited Financial Statements
|
3
|
||||||
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
28
|
||||||
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
35
|
||||||
|
Item 4.
|
Controls and Procedures
|
35
|
||||||
|
PART II
|
OTHER INFORMATION
|
37
|
||||||
|
Item 1.
|
Legal Proceedings
|
37
|
||||||
|
Item 1A.
|
Risk Factors
|
37
|
||||||
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
37
|
||||||
|
Item 3.
|
Defaults Upon Senior Securities
|
38
|
||||||
|
Item 4.
|
Mine Safety Disclosures
|
38
|
||||||
|
Item 5.
|
Other Information
|
38
|
||||||
|
|
Page
|
||||
|
Condensed Consolidated Balance Sheets
|
4
|
||||
|
Condensed Consolidated Statements of Operations
|
5
|
||||
|
Condensed Consolidated Statements of Changes in Convertible Preferred Stock, Stockholders' Equity and Non-Controlling Interest
|
6
|
||||
|
Condensed Consolidated Statements of Cash Flows
|
7
|
||||
|
Notes to Condensed Consolidated Financial Statements
|
8
|
||||
| March 31, 2026 | December 31, 2025 | ||||||||||
| (Unaudited) | (*) | ||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
|
Cash and cash equivalents
|
$ 7,128
|
$ 9,248
|
|||||||||
|
Restricted cash
|
599
|
131
|
|||||||||
|
Due from affiliates
|
8,504
|
6,937
|
|||||||||
|
Prepaid expenses
|
1,894
|
1,606
|
|||||||||
|
Notes receivable
|
10,569
|
13,069
|
|||||||||
|
Other current assets, net
|
3,305
|
2,651
|
|||||||||
|
Total current assets
|
31,999
|
33,642
|
|||||||||
|
Investments in Sponsored Programs
|
1,391
|
1,371
|
|||||||||
|
Property, software and equipment, net
|
24,482
|
28,783
|
|||||||||
|
Operating lease assets
|
2,795
|
2,915
|
|||||||||
|
Other assets, net
|
3,232
|
3,370
|
|||||||||
|
Total assets
|
$ 63,899
|
$ 70,081
|
|||||||||
| LIABILITIES | |||||||||||
| Current liabilities: | |||||||||||
|
Accounts payable
|
$ 2,002
|
$ 528
|
|||||||||
|
Accrued expenses
|
2,913
|
7,769
|
|||||||||
|
Operating lease liabilities, current
|
1,056
|
1,049
|
|||||||||
|
Other current liabilities
|
1,872
|
1,451
|
|||||||||
|
Total current liabilities
|
7,843
|
10,797
|
|||||||||
|
Operating lease liabilities, non-current
|
3,233
|
3,426
|
|||||||||
|
Other liabilities
|
-
|
292
|
|||||||||
|
Total liabilities
|
11,076
|
14,515
|
|||||||||
|
Commitments and contingencies (Note 16)
|
|||||||||||
|
Series A convertible preferred stock, $0.0001 par value; 15,000,000 shares authorized; 11,865,046 shares issued and outstanding; with an aggregate liquidation preference of $25,951
|
25,018
|
25,018
|
|||||||||
| STOCKHOLDERS' EQUITY | |||||||||||
|
Class A Common Stock, $0.0001 par value; 43,000,000 shares authorized; 2,891,359 shares issued and 2,458,394 shares outstanding
|
-
|
-
|
|||||||||
|
Class B Common Stock, $0.0001 par value; 38,000,000 shares authorized, 22,207,313 shares issued and 20,056,589 outstanding, 21,970,987 shares issued and 19,826,469 outstanding, respectively
|
2
|
2
|
|||||||||
|
Class F Common Stock, $0.0001 par value; 10,000,000 shares authorized; 10,000,000 shares issued and outstanding
|
1
|
1
|
|||||||||
|
Additional paid-in capital
|
204,248
|
200,586
|
|||||||||
|
Accumulated deficit
|
(187,714)
|
(182,298)
|
|||||||||
|
Total stockholders' equity before non-controlling interests
|
16,537
|
18,291
|
|||||||||
|
Non-controlling interests in consolidated entity
|
11,268
|
12,257
|
|||||||||
|
Total stockholders' equity
|
27,805
|
30,548
|
|||||||||
|
Total liabilities and stockholders' equity
|
$ 63,899
|
$ 70,081
|
|||||||||
|
Three Months Ended
March 31,
|
|||||||||||
| 2026 | 2025 | ||||||||||
|
Revenue
|
$ 17,529
|
$ 11,955
|
|||||||||
|
Costs and expenses
|
|||||||||||
|
Cost of revenue, exclusive of depreciation and amortization shown separately below
|
2,581
|
2,218
|
|||||||||
|
Technology and product development
|
6,129
|
5,560
|
|||||||||
|
Marketing
|
2,749
|
2,216
|
|||||||||
|
General, administrative and other
|
5,845
|
5,903
|
|||||||||
|
Depreciation and amortization
|
4,474
|
3,036
|
|||||||||
|
Total costs and expenses
|
21,778
|
18,933
|
|||||||||
|
Net operating loss
|
(4,249)
|
(6,978)
|
|||||||||
|
Other income
|
|||||||||||
|
Gain on extinguishment of debt
|
-
|
2,391
|
|||||||||
|
Dividend and interest income
|
272
|
328
|
|||||||||
| Equity in earnings |
22
|
18
|
|||||||||
|
Total other income
|
294
|
2,737
|
|||||||||
|
Net loss before income taxes
|
(3,955)
|
(4,241)
|
|||||||||
|
Income tax benefit (expense)
|
-
|
-
|
|||||||||
|
Net loss
|
(3,955)
|
(4,241)
|
|||||||||
|
Net income attributable to non-controlling interests
|
129
|
162
|
|||||||||
|
Net loss attributable to Rise Companies Corp.
|
$ (4,084)
|
$ (4,403)
|
|||||||||
| Net loss per share attributable to common stockholders: | |||||||||||
|
Basic (in dollars per share)*
|
$ (0.13)
|
$ (0.14)
|
|||||||||
|
Diluted (in dollars per share)*
|
(0.13)
|
(0.14)
|
|||||||||
|
Weighted average shares used to compute net loss per share attributable to common stockholders:
|
|||||||||||
|
Basic (in shares)*
|
32,404,261
|
32,546,024
|
|||||||||
| Diluted (in shares)* |
32,404,261
|
32,546,024
|
|||||||||
|
Preferred Stock
Series A
|
Common Stock
Class A
|
Common Stock
Class F
|
Common Stock
Class B
|
Additional Paid-In Capital | Accumulated Deficit | Non- Controlling Interests | Total Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Balance at December 31, 2025
|
11,865,046
|
$ 25,018
|
2,458,394
|
$ -
|
10,000,000
|
$ 1
|
19,826,469
|
$ 2
|
$ 200,586
|
$ (182,298)
|
$ 12,257
|
$ 30,548
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reclassification of Accumulated Deficit to NCI
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(1,332)
|
1,332
|
-
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Issuance of Class B Common Stock
|
-
|
-
|
-
|
-
|
-
|
-
|
236,326
|
-
|
3,758
|
-
|
-
|
3,758
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Redemption of Class B Common Stock
|
-
|
-
|
-
|
-
|
-
|
-
|
(6,206)
|
-
|
(73)
|
-
|
-
|
(73)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Offering costs for Class B Common Stock
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(23)
|
-
|
-
|
(23)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Distribution of Member's Equity of NCI
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(2,450)
|
(2,450)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Net income (loss)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(4,084)
|
129
|
(3,955)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Balance at March 31, 2026
|
11,865,046
|
$ 25,018
|
2,458,394
|
$ -
|
10,000,000
|
$ 1
|
20,056,589
|
$ 2
|
$ 204,248
|
$ (187,714)
|
$ 11,268
|
$ 27,805
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Preferred Stock
Series A
|
Common Stock
Class A
|
Common Stock
Class F
|
Common Stock
Class B
|
Additional Paid-In Capital | Accumulated Deficit | Non- Controlling Interests | Total Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Balance at December 31, 2024
|
11,865,046
|
$ 25,018
|
2,455,894
|
$ -
|
10,000,000
|
$ 1
|
20,075,183
|
$ 2
|
$ 200,811
|
$ (169,846)
|
$ 11,627
|
$ 42,595
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Issuance of Class B Common Stock
|
-
|
-
|
-
|
-
|
-
|
-
|
60,596
|
-
|
963
|
-
|
-
|
963
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Redemption of Class B Common Stock
|
-
|
-
|
-
|
-
|
-
|
-
|
(202,653)
|
-
|
(2,174)
|
-
|
-
|
(2,174)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Offering costs for Class B Common Stock
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(21)
|
-
|
-
|
(21)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Exercise of Common A RSOs
|
-
|
-
|
2,500
|
-
|
-
|
-
|
-
|
-
|
13
|
-
|
-
|
13
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Distribution of Member's Equity of NCI
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(53)
|
(53)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Net income (loss)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(4,403)
|
162
|
(4,241)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Balance at March 31, 2025
|
11,865,046
|
$ 25,018
|
2,458,394
|
$ -
|
10,000,000
|
$ 1
|
19,933,126
|
$ 2
|
$ 199,592
|
$ (174,249)
|
$ 11,736
|
$ 37,082
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended | Three Months Ended | ||||||||||
| March 31, 2026 | March 31, 2025 | ||||||||||
| Cash flows from operating activities | |||||||||||
|
Net loss
|
$ (3,955)
|
$ (4,241)
|
|||||||||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|||||||||||
|
Depreciation and amortization
|
4,474
|
3,036
|
|||||||||
|
(Gain) on extinguishment of debt
|
-
|
(2,391)
|
|||||||||
|
Amortization of capitalized promotions
|
74
|
164
|
|||||||||
|
Other non-cash, net
|
(18)
|
10
|
|||||||||
| Change in assets and liabilities: | |||||||||||
|
Net (increase) decrease in prepaid expenses and other assets
|
(1,012)
|
(1,382)
|
|||||||||
|
Net increase (decrease) in accounts payable and accrued expenses
|
(3,382)
|
(4,633)
|
|||||||||
|
Net increase (decrease) in other liabilities
|
61
|
386
|
|||||||||
|
Net (increase) decrease in due from affiliates
|
(1,567)
|
621
|
|||||||||
|
Net cash provided by (used in) operating activities
|
(5,325)
|
(8,430)
|
|||||||||
| Cash flows from investing activities | |||||||||||
|
Capitalized internal-use software development costs
|
-
|
(2,056)
|
|||||||||
|
Proceeds from payoff of notes receivable
|
2,500
|
-
|
|||||||||
|
Other, net
|
(38)
|
(56)
|
|||||||||
|
Net cash provided by (used in) investing activities
|
2,462
|
(2,112)
|
|||||||||
|
Cash flows from financing activities
|
|||||||||||
|
Distribution of Member's Equity of NCI
|
(2,451)
|
(53)
|
|||||||||
|
Proceeds from the issuance of Class B Common Stock, net of offering costs
|
3,735
|
942
|
|||||||||
|
Redemptions of Class B Common Stock
|
(73)
|
(1,449)
|
|||||||||
|
Payment of principal on loan payable
|
-
|
(374)
|
|||||||||
|
Proceeds from settling subscriptions
|
-
|
348
|
|||||||||
|
Net cash provided by (used in) financing activities
|
1,211
|
(586)
|
|||||||||
|
Net increase (decrease) in cash and cash equivalents
|
(1,652)
|
(11,128)
|
|||||||||
|
Cash, restricted cash and cash equivalents, beginning of period
|
9,379
|
21,155
|
|||||||||
|
Cash, restricted cash and cash equivalents, end of period
|
$ 7,727
|
$ 10,027
|
|||||||||
|
Supplemental disclosures of cash flow information
|
|||||||||||
|
Cash paid for interest
|
$ -
|
$ -
|
|||||||||
|
Cash paid for income taxes
|
-
|
-
|
|||||||||
| Supplemental disclosures of non-cash financing activity: | |||||||||||
|
Exercise of Class A Common Stock
|
$ -
|
$ 13
|
|||||||||
| Three Months Ended March 31, 2025 | |||||||||||||||||
| As Reported | Adjustment | As Revised | |||||||||||||||
| Revenue |
$ 13,415
|
$ (1,460)
|
$ 11,955
|
||||||||||||||
|
Costs and expenses
|
|||||||||||||||||
|
Marketing
|
3,676
|
(1,460)
|
2,216
|
||||||||||||||
|
Total costs and expenses
|
20,393
|
(1,460)
|
18,933
|
||||||||||||||
| Three Months Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
|
Numerator:
|
|||||||||||
|
Net loss
|
$ (3,955)
|
$ (4,241)
|
|||||||||
|
Less: net income attributable to noncontrolling interest
|
129
|
162
|
|||||||||
|
Net loss attributable to common stockholders
|
$ (4,084)
|
$ (4,403)
|
|||||||||
|
Denominator:
|
|||||||||||
|
Weighted-average common shares outstanding - basic and diluted
|
32,404,261
|
32,546,024
|
|||||||||
|
Net loss per share attributable to common stockholders - basic and diluted
|
$ (0.13)
|
$ (0.14)
|
|||||||||
| Three Months Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
|
Redeemable convertible preferred stock
|
11,865,046
|
11,865,046
|
|||||||||
|
Restricted stock units
|
9,320,642
|
8,968,830
|
|||||||||
|
Performance stock units
|
3,018,867
|
3,018,867
|
|||||||||
|
Restricted stock options
|
6,500
|
6,500
|
|||||||||
|
Total anti-dilutive securities
|
24,211,055
|
23,859,243
|
|||||||||
| Three Months Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Revenue: | |||||||||||
|
Investment management and platform advisory, net (1)
|
$ 9,632
|
$ 6,363
|
|||||||||
|
Real estate operating platform (2)
|
4,502
|
4,644
|
|||||||||
|
Real estate management
|
3,395
|
948
|
|||||||||
|
Total revenue
|
$ 17,529
|
$ 11,955
|
|||||||||
|
Operating
Leases
|
|||||
|
2026
|
$ 818
|
||||
|
2027
|
1,113
|
||||
|
2028
|
1,140
|
||||
|
2029
|
1,169
|
||||
|
2030
|
795
|
||||
|
Total future lease payments
|
5,035
|
||||
|
Less: Imputed interest
|
746
|
||||
|
Present value of lease liabilities
|
$ 4,289
|
||||
|
Lease liabilities, current
|
1,056
|
||||
|
Lease liabilities, non-current
|
3,233
|
||||
|
Present value of lease liabilities
|
$ 4,289
|
||||
| Three Months Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
|
Cash paid for amounts included in the measurement of lease liabilities:
|
|||||||||||
|
Operating cash flows
|
267
|
261
|
|||||||||
| March 31, 2026 | December 31, 2025 | ||||||||||
|
Internal-use software
|
$ 67,365
|
$ 67,365
|
|||||||||
|
Leasehold Improvements
|
1,668
|
1,668
|
|||||||||
|
Computer equipment
|
619
|
671
|
|||||||||
|
Furniture and fixtures
|
240
|
240
|
|||||||||
|
Total property, software and equipment
|
69,892
|
69,944
|
|||||||||
|
Less: accumulated amortization and depreciation
|
(45,410)
|
(41,161)
|
|||||||||
|
Total property, software and equipment, net
|
$ 24,482
|
$ 28,783
|
|||||||||
| March 31, 2026 | December 31, 2025 | ||||||||||
|
Accrued compensation and employee benefits
|
$ 2,077
|
$ 7,284
|
|||||||||
|
Accrued audit and tax expenses
|
351
|
241
|
|||||||||
|
Accrued legal expenses
|
281
|
-
|
|||||||||
|
Other accrued expenses
|
204
|
220
|
|||||||||
|
Accrued deferred costs of Sponsored Programs
|
-
|
24
|
|||||||||
|
Total
|
$ 2,913
|
$ 7,769
|
|||||||||
| March 31, 2026 | December 31, 2025 | ||||||||||
|
Employee benefit contributions payable
|
$ 1,135
|
$ 75
|
|||||||||
|
Deal-related deposits payable
|
392
|
512
|
|||||||||
|
Medical claims payable
|
30
|
861
|
|||||||||
|
Other current liabilities
|
315
|
3
|
|||||||||
|
Total
|
$ 1,872
|
$ 1,451
|
|||||||||
| Number of RSUs | Weighted-average grant date fair value | ||||||||||
|
Unvested restricted stock units at December 31, 2025
|
8,509,946
|
$ 13.73
|
|||||||||
|
Granted
|
932,618
|
15.90
|
|||||||||
|
Forfeited
|
(44,422)
|
12.35
|
|||||||||
|
Expired
|
(77,500)
|
6.90
|
|||||||||
|
Unvested restricted stock units at March 31, 2026
|
9,320,642
|
$ 14.01
|
|||||||||
|
Fair Value of Common Stock
|
$ 15.90
|
||||
|
Expected Volatility
|
59 %
|
||||
|
Expected Dividends
|
- %
|
||||
|
Risk-Free Rate
|
4.30 %
|
||||
|
Expected term (in years)
|
3.98 | ||||
| March 31, 2026 | December 31, 2025 | ||||||||||
|
Due from affiliates
|
$ 2,622
|
$ 2,240
|
|||||||||
|
Investments in Sponsored Programs
|
942
|
959
|
|||||||||
|
Other current assets, net
|
14
|
16
|
|||||||||
|
Other assets, net
|
1,846
|
1,846
|
|||||||||
|
Maximum Exposure to Loss
|
$ 5,424
|
$ 5,061
|
|||||||||
|
Amounts Due to Non-Consolidated VIEs
|
$ -
|
$ -
|
|||||||||
| March 31, 2026 | December 31, 2025 | ||||||||||
|
Investment management and platform advisory receivables
|
$ 4,625
|
$ 4,060
|
|||||||||
|
Real estate operating platform receivables
|
1,452
|
1,527
|
|||||||||
|
Real estate management receivables
|
4
|
48
|
|||||||||
|
Other receivables from affiliates (1)
|
2,423
|
1,302
|
|||||||||
|
Total
|
$ 8,504
|
$ 6,937
|
|||||||||
| Average Annual Non-Compounded Return | Liquidation Support Payment | |||||||
|
17.0% or less
|
$ 500
|
|||||||
|
17.1% to 18.0%
|
$ 400
|
|||||||
|
18.1% to 19.0%
|
$ 300
|
|||||||
|
19.1% to 19.9%
|
$ 200
|
|||||||
|
20.0% or greater
|
$ -
|
|||||||
| Results |
Three Months Ended
March 31, 2026
(in thousands)
|
Three Months Ended
March 31, 2025
(in thousands)
|
% Change
(from 2025)
|
Explanation | ||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||
|
Investment management and platform advisory, net
|
$ 9,632
|
$ 6,363
|
51 %
|
Investment management and platform advisory income, net increased period over period due to (i) higher asset management fees of approximately $1.7 million earned from increases in AUM, primarily driven by the Innovation Fund, and (ii) a net $1.9 million period-over-period impact related to operating expense reimbursements to the Innovation Fund ($1.5 million paid in Q1 2025 versus $0.4 million recouped in Q1 2026). | ||||||||||||||||||||||
|
Real estate operating platform
|
4,502
|
4,644
|
-3 %
|
Real estate operating platform income remained consistent due to relatively consistent underlying asset values period-over-period. | ||||||||||||||||||||||
|
Real estate management
|
3,395
|
948
|
258 %
|
Real estate management income increased period-over-period due to an increase in origination and disposition fees as a result of rising transaction activity. | ||||||||||||||||||||||
|
Total revenue
|
$ 17,529
|
$ 11,955
|
47 %
|
|||||||||||||||||||||||
| Results |
Three Months Ended
March 31, 2026
(in thousands)
|
Three Months Ended
March 31, 2025
(in thousands)
|
% Change
(from 2025)
|
Explanation | ||||||||||||||||||||||
| Costs and Expenses | ||||||||||||||||||||||||||
|
Cost of revenue, exclusive of depreciation and amortization shown separately below
|
Cost of revenue, exclusive of depreciation and amortization shown separately below, consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. | |||||||||||||||||||||||||
|
$ 2,581
|
$ 2,218
|
16 %
|
Cost of revenue expenses increased slightly period-over-period as a result of costs associated with operating RealAI. | |||||||||||||||||||||||
|
Technology and product development
|
Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through Depreciation and amortization over the term of their useful life. All other Technology and product development expenses are expensed as incurred. | |||||||||||||||||||||||||
|
$ 6,129
|
$ 5,560
|
10 %
|
Technology and product development expenses increased period-over-period due to fewer salaries and benefits being capitalized to internal-use software. | |||||||||||||||||||||||
|
Marketing
|
Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. | |||||||||||||||||||||||||
|
$ 2,749
|
$ 2,216
|
24 %
|
The increase in marketing expense period-over-period was due to increased marketing spend to support certain product marketing initiatives during the first quarter of 2026. | |||||||||||||||||||||||
|
General, administrative and other
|
General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. | |||||||||||||||||||||||||
|
Software and other office expenses
|
$ 713
|
$ 650
|
10 %
|
Software and other office expenses remained relatively consistent period-over-period and are mainly comprised of software subscription expenses supporting corporate functions and corporate office lease expense. | ||||||||||||||||||||||
|
Professional fees
|
607
|
565
|
7 %
|
Professional fees remained relatively consistent period-over-period and are mainly comprised of legal fees for certain advisory projects. | ||||||||||||||||||||||
|
Other general and administrative
|
4,525
|
4,688
|
-3 %
|
Other general and administrative expenses remained consistent period-over-period and are mainly comprised of salaries and benefits of personnel responsible for our corporate functions. | ||||||||||||||||||||||
|
Depreciation and amortization
|
Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. | |||||||||||||||||||||||||
|
$ 4,474
|
$ 3,036
|
47 %
|
Depreciation and amortization expense increased period-over-period due to (i) a $0.7 million increase in amortization of internal use software as more projects were in service in the current period, and (ii) an additional $0.7 million in accelerated amortization due to a change in useful life of an AI-related internal use software module. Refer to Note 7, Property, Software and Equipment, net in the Notes to the Condensed Consolidated Financial Statements for more information.
|
|||||||||||||||||||||||
|
Total costs and expenses
|
$ 21,778
|
$ 18,933
|
15 %
|
|||||||||||||||||||||||
| Results |
Three Months Ended
March 31, 2026
(in thousands)
|
Three Months Ended
March 31, 2025
(in thousands)
|
% Change
(from 2025)
|
Explanation | ||||||||||||||||||||||
| Other Income | ||||||||||||||||||||||||||
|
Gain on extinguishment of debt
|
$ -
|
$ 2,391
|
(100) %
|
In January 2025, the Company was notified that its Paycheck Protection Program (the "PPP loan") loan in the principal amount of $2.8 million was partially forgiven by the U.S. Small Business Administration (the "SBA") and the Company recorded a corresponding gain. Refer to Note 8, Loan Payable in the Notes to the Condensed Consolidated Financial Statements for more details.
|
||||||||||||||||||||||
|
Dividend and interest income
|
272
|
328
|
(17) %
|
Dividend and interest income decreased period-over-period largely due to a decrease in sweep dividends earned, due to a lower average daily cash balance and lower interest rates. | ||||||||||||||||||||||
|
Equity in earnings
|
22
|
18
|
22 %
|
Equity in earnings earned from Rise and its subsidiaries' investments in the Investment Products increased period-over-period due to the Investment Products' increase in net earnings period-over-period. | ||||||||||||||||||||||
|
Total other income
|
$ 294
|
$ 2,737
|
(89) %
|
|||||||||||||||||||||||
|
Period
|
Total Number of Shares
Purchased
|
Average Price Paid Per Share
|
Total Number of Shares Purchased As Part of Publicly Announced Plans or Programs
|
Maximum Number (or Approximate Dollar value) of Shares That May Yet Be Purchased Under the Plans or Programs
|
||||||||||||||||||||||
|
January 1, 2026 - January 31, 2026
|
6,019
|
$ 11.75
|
-
|
-
|
||||||||||||||||||||||
|
February 1, 2026 - February 28, 2026
|
187
|
$ 10.69
|
-
|
-
|
||||||||||||||||||||||
|
March 1, 2026 - March 31, 2026
|
-
|
$ -
|
-
|
-
|
||||||||||||||||||||||